Healthcare provider profile · identity verified

Christopher Pash, M.D.

Internal Medicine · LARGO, MD · NPI 1639121262

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1065	340
Amlodipine Besylate	Amlodipine Besylate	786	255
Losartan Potassium	Losartan Potassium	415	133
Lisinopril	Lisinopril	372	125
Metformin Hcl	Metformin Hcl	289	99
Albuterol Sulfate Hfa	Albuterol Sulfate	273	86
Gabapentin	Gabapentin	224	72
Glipizide	Glipizide	218	74
Tamsulosin Hcl	Tamsulosin Hcl	213	75
Furosemide	Furosemide	195	60
Metoprolol Tartrate	Metoprolol Tartrate	185	57
Hydrochlorothiazide	Hydrochlorothiazide	177	62
Levothyroxine Sodium	Levothyroxine Sodium	163	50
Atenolol	Atenolol	159	46
Meloxicam	Meloxicam	149	52
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	143	44
Allopurinol	Allopurinol	140	39
Pantoprazole Sodium	Pantoprazole Sodium	131	48
Simvastatin	Simvastatin	115	35
Arexvy	Rsvpref3 Antigen/As01e/Pf	113	113
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	111	24
Pradaxa	Dabigatran Etexilate Mesylate	109	39
Famotidine	Famotidine	97	32
Hydralazine Hcl	Hydralazine Hcl	89	34
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	84	27
Metformin Hcl Er	Metformin Hcl	82	31
Prednisone	Prednisone	80	61
Jardiance	Empagliflozin	77	27
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	74	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	74	20
Potassium Chloride	Potassium Chloride	73	20
Wixela Inhub	Fluticasone Propion/Salmeterol	73	22
Alprazolam	Alprazolam	65	11
Baclofen	Baclofen	63	30
Tramadol Hcl	Tramadol Hcl	62	23
Pregabalin	Pregabalin	59	13
Rosuvastatin Calcium	Rosuvastatin Calcium	59	22
Triamcinolone Acetonide	Triamcinolone Acetonide	58	24
Trazodone Hcl	Trazodone Hcl	57	18
Duloxetine Hcl	Duloxetine Hcl	56	suppressed
Methocarbamol	Methocarbamol	56	15
Carvedilol	Carvedilol	55	23
Latanoprost	Latanoprost	54	19
Clopidogrel	Clopidogrel Bisulfate	52	20
Doxazosin Mesylate	Doxazosin Mesylate	52	19
Colchicine	Colchicine	51	15
Pravastatin Sodium	Pravastatin Sodium	51	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	50	17
Metoprolol Succinate	Metoprolol Succinate	50	19
Pioglitazone Hcl	Pioglitazone Hcl	50	17
Alvesco	Ciclesonide	49	13
Finasteride	Finasteride	49	14
Terazosin Hcl	Terazosin Hcl	48	13
Lovastatin	Lovastatin	47	13
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	46	19
Warfarin Sodium	Warfarin Sodium	44	13
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	41	12
Shingrix	Varicella-Zoster Ge/As01b/Pf	41	39
Humulin N Kwikpen	Insulin Nph Human Isophane	40	12
Oxycodone Hcl	Oxycodone Hcl	38	suppressed
Spironolactone	Spironolactone	38	12
Ciclopirox	Ciclopirox Olamine	36	16
Eliquis	Apixaban	35	suppressed
Lactulose	Lactulose	34	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	29	29
Ibuprofen	Ibuprofen	29	suppressed
Spiriva Respimat	Tiotropium Bromide	29	11
Azelastine Hcl	Azelastine Hcl	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Humulin N	Insulin Nph Human Isophane	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Sertraline Hcl	Sertraline Hcl	26	13
Xarelto	Rivaroxaban	26	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	23	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Ondansetron Odt	Ondansetron	23	14
Alendronate Sodium	Alendronate Sodium	22	suppressed
Amoxicillin	Amoxicillin	22	15
Etodolac	Etodolac	22	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Humulin R	Insulin Regular, Human	21	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Hydrocortisone	Hydrocortisone	19	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	17
Lorazepam	Lorazepam	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Methylprednisolone	Methylprednisolone	17	16
Acyclovir	Acyclovir	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Nabumetone	Nabumetone	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Calcitriol	Calcitriol	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	11
Naloxone Hcl	Naloxone Hcl	14	11
Nystatin	Nystatin	14	suppressed
Azithromycin	Azithromycin	13	13
Cartia Xt	Diltiazem Hcl	13	11
Fluocinonide	Fluocinonide	13	suppressed
Clonidine	Clonidine	12	suppressed
Erythromycin	Erythromycin Base	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error